Influence of Physicochemical Properties of Budesonide Micro-Suspensions on Their Expected Lung Delivery Using a Vibrating Mesh NebulizerPHARMACEUTICSIF5.52023-02-231OAAI
Obesity and disease severity magnify disturbed microbiome-immune interactions in asthma patientsNATURE COMMUNICATIONSIF15.72019-12-13139OAAI
Rhinovirus triggers increased inflammasome activation in human bronchial epithelium in asthmaEUROPEAN RESPIRATORY JOURNALIF212017-12-063PRE
Evaluation of the Efficiency of Single-Inhaler Combination Therapy with Budesonide/Formoterol Fumarate in Patients with Bronchial Asthma in Daily Clinical PracticeADVANCES IN THERAPYIF42017-11-088OAAI
Inhalation devices: from basic science to practical use, innovative vs generic productsEXPERT OPINION ON DRUG DELIVERYIF5.42016-06-2035PREAI
NEXThaler, an innovative dry powder inhaler delivering an extrafine fixed combination of beclometasone and formoterol to treat large and small airways in asthmaEXPERT OPINION ON DRUG DELIVERYIF5.42014-06-1276OAAI
The New EU Legislation on Pharmacovigilance and Changing Models for Drug Development ReplyDRUG SAFETYIF3.82011-06-010PREAI
Strengthening and Rationalizing Pharmacovigilance in the EU: Where is Europe Heading to? A Review of the New EU Legislation on PharmacovigilanceDRUG SAFETYIF3.82011-03-0175PREAI
100 years of lung cancer (Retraction of vol 100, pg 2073, 2006)RESPIRATORY MEDICINEIF3.12009-08-011OAAI
RETRACTED: 100 years of lung cancer (Retracted article. See vol 103, pg 1244, 2009)RESPIRATORY MEDICINEIF3.12006-12-01122PREAI
Cost-effectiveness of fenspiride in adults with chronic bronchitis exacerbations in PolandVALUE IN HEALTHIF62005-11-010OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向